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Abstract 
Advanced glycation end products (AGEs) play an important factor for pathophysiology of diabetes and its complica-
tions. Moringa oleifera is one of the medicinal plants that have anti-hyperglycemic activity. However, anti-glycation 
property of Moringa oleifera leaf extract on the different types of reducing monosaccharides-induced protein glyca-
tion has not been investigated. Therefore, the aim of this study was to examine the protective effect of Moringa oleif-
era aqueous leaf extract (MOE) on reducing sugars-induced protein glycation and protein oxidation. Total phenolic 
content of MOE was measured using the Folin–Ciocalteu method. Bovine serum albumin was incubated with 0.5 M 
of reducing sugars (glucose or fructose) with or without MOE (0.5–2.0 mg/mL) for 1, 2, 3 and 4 weeks. The results 
found that total phenolic content was 38.56 ± 1.50 mg gallic acid equivalents/g dry extract. The formation of fluores-
cent and non-fluorescent AGEs [Nε-(carboxymethyl) lysine (CML)] and the level of fructosamine were determined to 
indicate protein glycation, whereas the level of protein carbonyl content and thiol group were examined for protein 
oxidation. MOE (0.5–2.0 mg/mL) significantly inhibited the formation of fluorescent, Nε-CML and markedly decreased 
fructosamine level (P < 0.05). Moreover, MOE significantly prevented protein oxidation manifested by reducing protein 
carbonyl and the depletion of protein thiol in a dose-dependent manner (P < 0.05). Thus, the findings indicated that 
polyphenols containing in MOE have high potential for decreasing protein glycation and protein oxidation that may 
delay or prevent AGE-related diabetic complications.
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Background
Advanced glycation end products (AGEs) are a complex 
of heterogeneous group of molecules that are formed 
from non-enzymatic glycation of carbonyl group of a 
reducing sugar with an amino group of proteins, lipids, 
or nucleic acids (Kaneko et  al. 2005). The accumulation 
of AGEs in various types of tissues causes the altera-
tion of proteins leading to change their characteristics, 
physiochemical, and biochemical properties (Vanessa 
et  al. 2013). The interaction of AGEs with the recep-
tor of advanced glycation end products evokes oxidative 
stress and subsequently elicits vascular inflammation and 
thrombosis (Kang 2003). Studies have also shown that 
reactive oxygen species (ROS) formed by AGEs cause 
DNA damage and induction of cell apoptosis (Kang 
2003). Glucose and fructose, the most common reduc-
ing sugar found in blood circulation react spontane-
ously with amino groups of proteins to AGEs. Although 
glucose plays a vital role in the formation of AGEs, it 
is now known that fructose undergoes protein glyca-
tion much faster than glucose (Semchyshyn et al. 2014). 
Endogenous fructose production by the sorbitol pathway 
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is also considered to contribute the formation of AGEs 
and consequently accumulate in the tissues (Suarez et al. 
1989; Vinson and Howard 1996). There are several clini-
cal studies which demonstrate the link between the long-
term consumption of fructose and the development of 
aging process (Levi and Werman 1998). Therefore, there 
has been seriously concern regarding the critical role of 
fructose in the glycation process. Studies on antiglycat-
ing agents have recently emerged as the new therapeutic 
approaches in preventing AGE-related diseases (Adi-
sakwattana et al. 2010). Aminoguanidine (AG) is one of 
therapeutic agents for use in the prevention of AGE for-
mation by cleavage of AGE-induced chemical cross-links 
(Brownlee et  al. 1986). However, it has shown serious 
side effects including vascularitis, gastrointestinal dis-
turbances, and anemia (Brownlee et  al. 1986). For this 
reason, the search for alternative prevention of AGE for-
mation has been focused on the natural products.
Polyphenolic compounds are commonly found in veg-
etables, fruits, spices, and medicinal herbs. Previously, 
it has been shown that polyphenols play an important 
role in human health, including reduced risk of chronic 
and degenerative diseases (Vauzour et al. 2010; Ngamu-
kote et  al. 2011; Adisakwattana and Chanathong 2011). 
Moringa oleifera (Ma-rum) is the most widely cultivated 
species of a monogeneric family, the Moringaceae which 
is commonly found in tropical countries such as India, 
Afghanistan, as well as Thailand. In addition, Many stud-
ies have reported the flavonoid contents such as keam-
ferol, quercetin, ferulic acid, gallic acid, rutin, caffeic acid 
as well as other phenolic compounds in multi-part of 
Moringa tree (Fahey 2005; Anwar et al. 2007). A number 
of previous studies have reported pharmacological prop-
erties of Moringa oleifera particular in antioxidant prop-
erty and antidiabetic activity that may provide benefits 
for diabetic patients (Jaiswal et al. 2009; Chumark et al. 
2008; Adisakwattana and Chanathong 2011). However, 
there are no reports in the literature showing that MOE 
can inhibit protein glycation induced by different types 
of reducing monosaccharaides in vitro models. Thus, the 
aim of present study was to evaluate the inhibitory effects 
of MOE on glucose- and fructose-induced protein glyca-
tion, about which no previous reports exist. Furthermore, 
the inhibitory effects of MOE on oxidation-dependent 




Glucose, fructose, and 2,4-dinitrophenyl hydra-
zine (DNPH) were purchased from Ajax Finechem 
(Taren Point, Australia). Catechin, gallic acid, sodium 
azide, Nitroblue tetrazolium (NBT), aminoguanidine 
hydrochloride (AG), guanidine hydrochloride, Thiofla-
vin T (ThT), 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), 
and l-cysteine were obtained from Sigma-Aldrich Co. 
(St. Louis, MO, USA). Trichloroacetic acid (TCA) was 
purchased from Merck (Darmstadt, Germany). OxiSe-
lectTM CML ELISA kit was purchased from Cell Biolabs 
(San Diego, CA, USA). All other reagents used were of 
analytical grade.
Preparation of Moringa oleifera aqueous leaf extract
The leaves of Moringa oleifera were obtained from local 
areas of Bangkok in Nongkhame district, Thailand. The 
herbarium number of A014172 (BCU) was authenti-
cated by a Taxonomist at Department of Botany, Fac-
ulty of Science, Chulalongkorn University, Thailand. The 
dried leaves (250  g) were extracted with distilled water 
twice (3 L) for 3 h at 100 °C. The extraction was filtered 
through Whatman No. 1 filter paper under the vacuum. 
The filtrate was further subjected to a spray dryer SD-100 
(Eyela world, Tokyo Rikakikai Co., LTD, Japan) to obtain 
the extract powder. The spray drying conditions, inlet 
and outlet air temperature was set at 160 and 89–99 °C, 
respectively.
Determination of total phenolic content
Total phenolic content of Moringa oleifera leaf extract 
(MOE) was determined by the Folin-Ciocalteu method 
(Verma et al. 2009). The extract powder was dissolved in 
distilled water (1.25 mg/mL). The freshly prepared Folin-
Ciocalteu reagent was gently mixed with 10  µL of sam-
ple. Then, 75 µL of 7.5 % sodium carbonate (Na2CO3) was 
added and allowed to stand for 30 min at room tempera-
ture in the dark. The mixture was measured at 725 nm by 
a spectrophotometer. Gallic acid (0.025–0.4 mg/mL) was 
used as a standard and the content of total phenolics was 
expressed as mg gallic acid equivalents/g dried extract.
Preparation of glycated bovine serum albumin (BSA)
Glycated BSA was performed according to a previously 
described method (Povichit et al. 2010) with slight modi-
fications. Briefly, BSA (10  mg/mL) was incubated with 
glucose or fructose (0.5  M) in 0.1  M phosphate buffer 
(pH 7.4) containing 0.02 % sodium azide (NaN3) with or 
without (MOE) (0.5–2.0  mg/mL) and aminoguanidine 
(AG, 1.0 mg/mL) at 37 °C for 4 weeks. Samples were kept 
at −20 °C until analysis.
Determination of advanced glycation end product (AGE) 
formation
The fluorescent AGEs, the irreversible products at the 
end stage of non-enzymatic glycation, were determined 
by a spectrofluorometer (Wallac 1420 Victor3  V, Perki-
nElmer, Santa Clara, CA, USA) at excitation and emission 
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wavelengths of 355  nm and 460  nm, respectively (Povi-
chit et al. 2010).
Determination of Nε‑(carboxymethyl) lysine (CML)
Non-fluorescent AGEs, Nε-(carboxymethyl) lysine (Nε-
CML), is the most abundant product of glycation reac-
tion. Commercially available ELISA kit was used for 
measurement of Nε-CMLformation (Cell Biolabs, CA, 
USA).
Determination of fructosamine
The levels of fructosamine was analyzed by nitroblue-
tetrazolium (NBT) assay with minor modification 
(Armbruster 1987). Briefly, 90 µL of 2.5 mM nitrobluetet-
razolium (NBT) reagent was added to 10 µL of glycated 
BSA in carbonate buffer (pH 10.3). After 10 and 15 min 
of incubation, the mixture was measured at 590 nm. The 
concentration of fructosamine was calculated by using 
the different absorption at 10 and 15  min time points 
compared with the standard 1-deoxy-1-morpholino-
fructose (1-DMF) curve.
Determination of protein carbonyl
Protein carbonyl content were determined according to 
a previously published method with minor modifications 
(Levine et  al. 1990). In brief, 10  mM 2,4-dinitrophenyl-
hydrazine (DNPH) in 2.5  M HCl (400  µL) was added 
to 100 µL of glycated BSA and incubated in the dark at 
room temperature for 60 min. Then, 20 % (w/v) trichlo-
roacetic acid (500 µL) was added and kept on ice for 
5 min. Protein precipitation was centrifuged and the pro-
tein pellet was then washed with 1:1 (v/v) ethanol/ethyl 
acetate and dissolved in 6  M guanidine hydrochloride. 
The absorbance was determined at 370 nm. The concen-
tration of protein carbonyl content was calculated using 
an absorption coefficient of 22,000 M−1cm−1. The results 
were expressed as nmol carbonyl/mg protein.
Determination of protein thiol groups
The determination of free thiol groups were performed 
according to Ellman’s assay using 5,5′-dithiobis-(2-ni-
trobenzoic acid) (DTNB) (Ellman 1959). Glycated BSA 
(10 µL) was incubated with 6 mM DTNB in 0.1 M PBS 
(pH 7.4) for 15 min at room temperature. The absorbance 
was determined at 410 nm. The free thiol concentration 
was calculated for the standard curve of l-cysteine (0.3–
10 µM) and expressed as nmol/mg protein.
Statistical analysis
Data are expressed as mean  ±  standard error of mean 
(SEM) of triplicate determination (n  =  3). Differences 
among groups were analyzed for statistical significance 
by one-way ANOVA followed by Duncan as post hoc 




In the present study, the content of total phenolic com-
pounds in Moringa oleifera leaf extract (MOE) was 
38.56 ± 1.50 mg gallic acid equivalents/g extract.
Effect of Moringa oleifera leaf extract on the different types 
of reducing monosaccharide‑induced fluorescent AGE 
formation
The formation of fluorescent AGEs in different monosac-
charide-induced protein glycation was monitored during 
4 weeks of incubation. As shown in Fig. 1, the significant 
increase in fluorescent intensity in BSA incubated with 
glucose and fructose was seen during 4  weeks of the 
incubation. The results demonstrated that the fluores-
cent AGE formation was increased 3.24-fold in glucose 
model (Fig. 1A) and 5.76-fold in fructose model (Fig. 1B) 
whereas MOE (0.5–2.0 mg/mL) inhibited the formation 
of AGEs in a dose-dependent manner during experimen-
tal periods both glucose and fructose models at week 4. 
The percentage inhibition of AGE formation by MOE 
(0.5–2.0 mg/mL) ranged from 14.52–40.65 % in glucose-
glycated BSA and 45.82–65.43  % in fructose-glycated 
BSA. However, MOE has less potent in the inhibition 
of AGE formation when compared with AG at the same 
concentration (1 mg/mL).
Effect of Moringa oleifera leaf extract on the level 
of Nε‑(carboxymethyl) lysine (CML)
In order to examine the formation of non-fluorescent 
AGEs, the level of Nε-CML was measured at week 4 of 
incubation. As shown in Fig. 2, it was found that the level 
of Nε-CML dramatically increased in glucose-glycated 
BSA (3.10-fold) and fructose-glycated BSA (8.60-fold). 
Conversely, the addition of MOE to the solution (1.0 mg/
mL) inhibited Nε-CML formation about 31.02 % in glu-
cose-glycated BSA and  about 66.82 % in fructose-gly-
cated BSA, whereas AG (1.0 mg/mL) inhibited Nε-CML 
formation about 44.17 % in glucose-glycated BSA and 
about 72.45 % in fructose-glycated BSA.
Effect of Moringa oleifera leaf extract on the level 
of fructosamine
The effects of MOE on the level of fructosamine are 
shown in Fig. 3. The level of fructosamine in glucose-gly-
cated BSA and fructose-glycated BSA markedly increased 
throughout 4  weeks of the experiment. In contrast, the 
increasing level of fructosamine was attenuated by MOE 
(0.5–2.0 mg/mL) during 4 weeks of the study. At week 4 
of incubation, MOE (0.5–2.0  mg/mL) reduced the level 
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of fructosamine in a concentration-dependent manner in 
glucose-glycated BSA (71.21–80.30  %) and fructose-gly-
cated BSA (18.96–49.56  %). In addition, the percentage 
reduction of fructosamine by AG (1 mg/mL) was 42.92 % 
for glucose-glycated BSA and 45.45  % for fructose-gly-
cated BSA.
Effect of Moringa oleifera leaf extract on the level of protein 
carbonyl content and protein thiol groups
The level of carbonyl content and thiol groups were used for 
indication of the protein oxidation mediated by glycation 
process. As shown in Fig.  4, the carbonyl content of glu-
cose-glycated BSA and fructose-glycated BSA significantly 
increased during the experimental period, whereas MOE 
(0.5–2.0  mg/mL) significantly suppressed an increase in 
protein carbonyl content of glucose-glycated BSA and fruc-
tose-glycated BSA. When comparing with glucose-glycated 
BSA and fructose-glycated BSA at week 4, the percentage 
reduction of carbonyl content by MOE (0.5–2.0  mg/mL) 
ranged from 51.12 to 76.31 % in glucose-glycated BSA and 
58.79 to 77.76  % in fructose-glycated BSA. A significant 
reduction of protein carbonyl content (91.59 % for glucose-
glycated BSA and 88.29 % for fructose-glycated BSA) was 
observed in the presence of AG (1  mg/mL) at the same 
week. The effects of MOE on the oxidation of protein thi-
ols are presented in Fig. 5. When BSA was incubated with 
glucose or fructose, the level of thiol groups had con-
tinuously declined throughout the experimental periods. 
Fig. 1 The effect of Moringa oleifera leaf extract (MOE, 0.5–2.0 mg/
mL) and aminoguanidine (AG, 1.0 mg/mL) on the formation of 
fluorescent AGEs in A bovine serum albumin (BSA) incubated with 
0.5 M glucose (glu) and B bovine serum albumin (BSA) incubated 
with 0.5 M fructose (fr) at week 1, 2, 3 and 4 of incubation. The results 
are expressed as mean ± SEM (n = 3). aP < 0.05 when compared to 
BSA alone, bP < 0.05 when compared to BSA with glucose (BSA/glu) 
or BSA with fructose (BSA/fr) at the same week of incubation Fig. 2 The effect of Moringa oleifera leaf extract (MOE, 1.0 mg/
mL) and aminoguanidine (AG, 1.0 mg/mL) on the level of Nε-
(carboxymethyl) lysine (CML) in A bovine serum albumin (BSA) incu-
bated with 0.5 M glucose (glu) and B bovine serum albumin (BSA) 
incubated with 0.5 M fructose (fr) at week 4 of incubation. The results 
are expressed as mean ± SEM (n = 3). aP < 0.05 when compared to 
BSA alone, bP < 0.05 when compared to BSA with glucose (BSA/glu) 
or BSA with fructose (BSA/fr) at the same week of incubation
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Interestingly, there was a significant increase in the level of 
thiol groups after addition of MOE (0.5–2.0 mg/mL) as well 
as AG (1.0 mg/mL). The findings showed that the percent-
age prevention of depleting thiol group by MOE ranged 
from 7.57 to 9.77  % in glucose-glycated BSA and 5.73 to 
10.32 % in fructose-glycated BSA, whereas AG (1.0 mg/mL) 
significantly prevented the depletion of protein thiol groups 
around 9.46  % and 14.09 % in glucose-glycated BSA and 
fructose-glycated BSA, respectively at the week 4. 
Discussion
In a present study, MOE was investigated the effect on 
glucose- and fructose-induced florescent and non-flu-
orescent AGE formation. The results showed that MOE 
efficiently inhibited fluorescent and non-fluorescent AGE 
formation. MOE also reduced the level of fructosamine 
associated with the reduction of AGE formation in glu-
cose-glycated BSA and fructose-glycated BSA. A signifi-
cant decrease of protein carbonyl content and oxidation 
of thiols in BSA were seen when MOE was added to the 
systems, it markedly suppressed these processes. The 
blockage of the carbonyl group in reducing sugars, the 
trapping of reactive oxygen species (ROS) and carbonyls 
during glycation, and breaking the crosslinking structure 
in the formed AGEs have recently been revealed as the 
underlying mechanisms of antiglycating agents (Price 
et al. 2001). The scavenging free radical generation dur-
ing glycation process may highlight other mechanisms 
for the prevention of AGE formation (Rout and Baner-
jee 2007). The Amadori products can be fragmented 
and consequently generate superoxide anion to form 
Fig. 3 The effect of Moringa oleifera leaf extract (MOE, 0.5–2.0 mg/
mL) and aminoguanidine (AG, 1.0 mg/mL) on fructosamine level in 
A bovine serum albumin (BSA) incubated with 0.5 M glucose (glu) 
and B bovine serum albumin (BSA) incubated with 0.5 M fructose 
(fr) at week 1, 2, 3 and 4 of incubation. The results are expressed 
as mean ± SEM (n = 3). aP < 0.05 when compared to BSA alone, 
bP < 0.05 when compared to BSA with glucose (BSA/glu) or BSA with 
fructose (BSA/fr) at the same week of incubation
Fig. 4 The effect of Moringa oleifera leaf extract (MOE, 0.5–2.0 mg/
mL) and aminoguanidine (AG, 1.0 mg/mL) on protein carbonyl con-
tent in A bovine serum albumin (BSA) incubated with 0.5 M glucose 
(glu) and B bovine serum albumin (BSA) incubated with 0.5 M fruc-
tose (fr) at week 1, 2, 3 and 4 of incubation. The results are expressed 
as mean ± SEM (n = 3). aP < 0.05 compared to BSA alone, bP < 0.05 
when compared to BSA with glucose (BSA/glu) or BSA with fructose 
(BSA/fr) at the same week of incubation
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fluorescent and non-fluorescent AGEs at the early stage 
of glycation (Peyroux and Sternberg 2006). An excess 
production of ROS causes oxidative damage to pro-
teins which lead to introduce carbonyl groups on the 
side chain of proteins and deplete thiol group of protein 
(Dalle-Donne et al. 2003).
Recent studies have shown that polyphenolic com-
pounds from the edible plants play a vital role to protect 
monosaccharide-induced protein glycation and oxidation 
(Adisakwattana et al. 2010). Additionally, there is a strong 
link between the polyphenolic content in the tested plant 
extracts and the ability to inhibit AGE formation (Peng 
et  al. 2011; Wu and Yen 2005). Evidence also supports 
that the inhibitory effect of polyphenols against protein 
glycation is strongly related to their ability of scaveng-
ing free radical derived from the glycoxidation process 
(Povichit et al. 2010). Our findings indicate that MOE has 
high content of polyphenolic compounds. The content of 
total phenolic compounds in Moringa oleifera leaf extract 
(MOE) was consistent with previous studies that the con-
tent of total phenolic compounds in MOE ranged 33.82–
45.21  mg gallic acid equivalents/g extract. According to 
the results obtained, we addressed the hypothesis that 
polyphenolic compounds in MOE may be a major con-
tributor to inhibit the formation of AGEs. Previous stud-
ies have demonstrated that MOE has antioxidant activity 
against free radicals including DPPH free radical, super-
oxide, hydroxyl and nitric oxide radical (Siddhuraju and 
Becker 2003). Therefore, the inhibitory effect of MOE on 
glycation-induced protein oxidation may be due to its 
antioxidant properties. However, certain active biologi-
cal constituents of MOE remain unknown. To prove this 
hypothesis, separation and characterization of polyphe-
nolic compound in MOE using HPLC–MS are required 
for further study.
Conclusion
Moringa oleifera aqueous leaf extract effectively inhib-
its reducing monosaccharide-induced AGE formation, 
protein oxidation and protein cross-linking in glycation 
reaction. This finding could be suggested that Moringa 
oleifera aqueous leaf extract may be used as an anti-
glycation agent to prevent the progression of diabetic 
complications.
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